By analysis of a publicly available database in the cBioPortal for Cancer Genomics (http://www.cbioportal.org/), we found that ZNF706 exhibited various genetic abnormalities in multiple malignancies, including bladder cancer, ovarian cancer, liver cancer, and prostate cancer. This evidence concerns the gene ZNF706 and urinary bladder cancer.